Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
aldesleukin interleukin-2 NA Successful target TTD , DGIDB Renal Cell Carcinoma[MeSHID:D002292]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.5 approved unknown
aldesleukin interleukin-2 receptor subunit alpha biotech NA drugbank , DGIDB Renal Cell Carcinoma[MeSHID:D002292]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.49 approved agonist,modulator
aldesleukin interleukin-2 receptor subunit beta biotech NA drugbank , DGIDB Renal Cell Carcinoma[MeSHID:D002292]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 23.87 approved agonist,modulator
aldesleukin cytokine receptor common subunit gamma biotech NA drugbank , DGIDB Renal Cell Carcinoma[MeSHID:D002292]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 25.46 approved agonist
click here to return to the previous page